Fintel reports that on November 18, 2024, Wells Fargo upgraded their outlook for CVS Health (XTRA:CVS) from Equal-Weight to Overweight.
Analyst Price Forecast Suggests 20.20% Upside
As of October 22, 2024, the average one-year price target for CVS Health is 60,91 €/share. The forecasts range from a low of 51,07 € to a high of 84,88 €. The average price target represents an increase of 20.20% from its latest reported closing price of 50,67 € / share.
See our leaderboard of companies with the largest price target upside.
The projected annual revenue for CVS Health is 329,948MM, a decrease of 10.16%. The projected annual non-GAAP EPS is 9.14.
What is the Fund Sentiment?
There are 3,088 funds or institutions reporting positions in CVS Health. This is an decrease of 105 owner(s) or 3.29% in the last quarter. Average portfolio weight of all funds dedicated to CVS is 0.36%, an increase of 10.34%. Total shares owned by institutions increased in the last three months by 1.18% to 1,289,127K shares.
What are Other Shareholders Doing?
BlackRock holds 104,550K shares representing 8.31% ownership of the company.
Dodge & Cox holds 63,031K shares representing 5.01% ownership of the company. In its prior filing, the firm reported owning 61,683K shares , representing an increase of 2.14%. The firm increased its portfolio allocation in CVS by 2.51% over the last quarter.
Capital World Investors holds 48,221K shares representing 3.83% ownership of the company. In its prior filing, the firm reported owning 56,024K shares , representing a decrease of 16.18%. The firm decreased its portfolio allocation in CVS by 12.88% over the last quarter.
DODGX - Dodge & Cox Stock Fund holds 41,232K shares representing 3.28% ownership of the company. In its prior filing, the firm reported owning 27,544K shares , representing an increase of 33.20%. The firm increased its portfolio allocation in CVS by 11.43% over the last quarter.
VTSMX - Vanguard Total Stock Market Index Fund Investor Shares holds 39,661K shares representing 3.15% ownership of the company. In its prior filing, the firm reported owning 39,567K shares , representing an increase of 0.24%. The firm decreased its portfolio allocation in CVS by 27.82% over the last quarter.
Fintel is one of the most comprehensive investing research platforms available to individual investors, traders, financial advisors, and small hedge funds.
Our data covers the world, and includes fundamentals, analyst reports, ownership data and fund sentiment, options sentiment, insider trading, options flow, unusual options trades, and much more. Additionally, our exclusive stock picks are powered by advanced, backtested quantitative models for improved profits.
This story originally appeared on Fintel.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
